| Urological Disorders and Treatments | Lifetime | 117 | US 73 | 99.24 |
| Genital Health and Disease | Lifetime | 66 | US 33 | 99.18 |
| Urologic and reproductive health conditions | Lifetime | 111 | US 61 | 99.24 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 209 | US 118 | 99.08 |
| Urinary and Genital Oncology Studies | Lifetime | 140 | US 84 | 99.00 |
| Renal cell carcinoma treatment | Lifetime | 323 | US 179 | 98.49 |
| Colorectal and Anal Carcinomas | Lifetime | 355 | US 139 | 97.73 |
| Cervical Cancer and HPV Research | Lifetime | 580 | US 255 | 97.44 |
| Testicular diseases and treatments | Lifetime | 277 | US 118 | 96.98 |
| Renal and related cancers | Lifetime | 792 | US 391 | 96.62 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 858 | US 409 | 97.45 |
| COVID-19 and healthcare impacts | Lifetime | 891 | US 321 | 92.19 |
| Female Genital Mutilation/Cutting Issues | Lifetime | 287 | US 113 | 85.66 |
| Infectious Disease Case Reports and Treatments | Lifetime | 272 | US 141 | 82.73 |
| Tuberous Sclerosis Complex Research | Lifetime | 575 | US 274 | 83.39 |
| Male Reproductive Health Studies | Lifetime | 870 | US 270 | 76.34 |
| Genital Health and Disease | 2021-2025 | 1 | US 1 | 99.73 |
| Urologic and reproductive health conditions | 2021-2025 | 2 | US 1 | 99.53 |
| Urological Disorders and Treatments | 2021-2025 | 13 | US 1 | 99.14 |
| Colorectal and Anal Carcinomas | 2021-2025 | 40 | US 15 | 97.87 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 103 | US 44 | 98.63 |
| Renal cell carcinoma treatment | 2021-2025 | 133 | US 55 | 97.59 |
| Urinary and Genital Oncology Studies | 2021-2025 | 95 | US 39 | 97.58 |
| COVID-19 and healthcare impacts | 2021-2025 | 835 | US 284 | 89.94 |
| Cervical Cancer and HPV Research | 2021-2025 | 365 | US 114 | 93.09 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 483 | US 303 | 88.55 |
| Testicular diseases and treatments | 2021-2025 | 150 | US 41 | 86.88 |
| Renal and related cancers | 2021-2025 | 628 | US 243 | 85.52 |
| Cancer Diagnosis and Treatment | 2021-2025 | 986 | US 241 | 73.51 |
| Female Genital Mutilation/Cutting Issues | 2021-2025 | 377 | US 142 | 56.63 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 988 | US 307 | 18.99 |
